Anna Filonenko

983 total citations
34 papers, 678 citations indexed

About

Anna Filonenko is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Reproductive Medicine. According to data from OpenAlex, Anna Filonenko has authored 34 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Public Health, Environmental and Occupational Health, 12 papers in Pediatrics, Perinatology and Child Health and 11 papers in Reproductive Medicine. Recurrent topics in Anna Filonenko's work include Reproductive Health and Contraception (14 papers), Global Maternal and Child Health (11 papers) and Endometriosis Research and Treatment (8 papers). Anna Filonenko is often cited by papers focused on Reproductive Health and Contraception (14 papers), Global Maternal and Child Health (11 papers) and Endometriosis Research and Treatment (8 papers). Anna Filonenko collaborates with scholars based in Germany, United States and United Kingdom. Anna Filonenko's co-authors include James Trussell, Fareen Hassan, Amy Law, Nathaniel Henry, Lothar Heinemann, Thai Do Minh, Julia Lowin, Klaas Heinemann, Mari‐Ann Wallander and Luis A. Garcı́a Rodrı́guez and has published in prestigious journals such as Fertility and Sterility, Clinical Therapeutics and Value in Health.

In The Last Decade

Anna Filonenko

32 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Filonenko Germany 14 525 286 161 155 134 34 678
Lem Ngongalah United Kingdom 8 216 0.4× 220 0.8× 245 1.5× 56 0.4× 14 0.1× 13 536
Heather Straub United States 10 246 0.5× 176 0.6× 230 1.4× 64 0.4× 10 0.1× 26 462
M. Bridget Spelke United States 12 176 0.3× 145 0.5× 60 0.4× 53 0.3× 18 0.1× 20 343
Andargachew Kassa Ethiopia 13 120 0.2× 142 0.5× 48 0.3× 75 0.5× 13 0.1× 28 387
Amos Grünebaum United States 14 93 0.2× 315 1.1× 276 1.7× 60 0.4× 11 0.1× 41 494
Claire A. Wood United States 12 191 0.4× 161 0.6× 31 0.2× 55 0.4× 23 0.2× 30 447
Swati Bhave India 8 203 0.4× 376 1.3× 180 1.1× 20 0.1× 11 0.1× 28 575
Teresa S. Johnson United States 13 95 0.2× 189 0.7× 67 0.4× 46 0.3× 14 0.1× 29 366
Peter St. Marie United States 12 87 0.2× 95 0.3× 53 0.3× 51 0.3× 34 0.3× 21 286
Marci Adams United States 13 365 0.7× 237 0.8× 207 1.3× 36 0.2× 8 0.1× 29 600

Countries citing papers authored by Anna Filonenko

Since Specialization
Citations

This map shows the geographic impact of Anna Filonenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Filonenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Filonenko more than expected).

Fields of papers citing papers by Anna Filonenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Filonenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Filonenko. The network helps show where Anna Filonenko may publish in the future.

Co-authorship network of co-authors of Anna Filonenko

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Filonenko. A scholar is included among the top collaborators of Anna Filonenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Filonenko. Anna Filonenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Haberland, Claudia, Anna Filonenko, Christian Seitz, et al.. (2020). Validation of a menstrual pictogram and a daily bleeding diary for assessment of uterine fibroid treatment efficacy in clinical studies. Journal of Patient-Reported Outcomes. 4(1). 97–97. 5 indexed citations
3.
Filonenko, Anna, et al.. (2019). PIH36 ECONOMIC BURDEN OF UNINTENDED PREGNANCY IN THE UNITED STATES. Value in Health. 22. S188–S189. 1 indexed citations
4.
Goeminne, Pieter, Roland Diel, Anna Filonenko, et al.. (2019). The economic burden of bronchiectasis – known and unknown: a systematic review. BMC Pulmonary Medicine. 19(1). 54–54. 56 indexed citations
6.
Gater, Adam, Adam Moore, Cheryl D. Coon, et al.. (2015). Measuring The Symptoms And Impacts Of Endometriosis: Psychometric Validation Of The Endometriosis Symptom Diary And Endometriosis Impact Scale. Value in Health. 18(3). A26–A26. 3 indexed citations
7.
Black, Amanda, Édith Guilbert, Fareen Hassan, et al.. (2015). The Cost of Unintended Pregnancies in Canada: Estimating Direct Cost, Role of Imperfect Adherence, and the Potential Impact of Increased Use of Long-Acting Reversible Contraceptives. Journal of Obstetrics and Gynaecology Canada. 37(12). 1086–1097. 41 indexed citations
8.
Filonenko, Anna, et al.. (2015). Sensitivity and specificity of the cerebral blood flow reactions to acupuncture in the newborn infants presenting with hypoxic ischemic encephalopathy. Problems of Balneology Physiotherapy and Exercise Therapy. 92(1). 27–27. 1 indexed citations
9.
Lete, Iñaki, Fareen Hassan, Eifiona Wood, et al.. (2015). Direct costs of unintended pregnancy in Spain. The European Journal of Contraception & Reproductive Health Care. 20(4). 308–318. 18 indexed citations
10.
Trussell, James, Fareen Hassan, Julia Lowin, Amy Law, & Anna Filonenko. (2014). Achieving cost-neutrality with long-acting reversible contraceptive methods. Contraception. 91(1). 49–56. 54 indexed citations
11.
Lowin, Julia, et al.. (2014). Direct Costs of Unintended Pregnancy in the Russian Federation. Applied Health Economics and Health Policy. 13(1). 61–68. 3 indexed citations
12.
Clerson, Pierre, Olivier Graesslin, Adam Gater, et al.. (2014). EVAPIL-R Scale: Continuous Development and Validation of a Tool to Assess Patient-Reported Tolerability of Different Contraceptive Methods in Longitudinal Studies. Clinical Therapeutics. 36(5). 638–647.e3. 4 indexed citations
13.
Gater, Adam, et al.. (2014). Assessing the content validity of the endometriosis symptom diary and endometriosis impact scale. Value in Health. 17(3). A198–A199. 2 indexed citations
14.
Chuang, Ling‐Hsiang, M. Treur, Bart Heeg, Ben van Hout, & Anna Filonenko. (2013). The use and impact of value of information analysis in decision-making. Value in Health. 16(3). A30–A30. 1 indexed citations
15.
Ganz, Michael L., Dhvani Shah, Risha Gidwani, et al.. (2013). The Cost-Effectiveness of the Levonorgestrel-Releasing Intrauterine System for the Treatment of Idiopathic Heavy Menstrual Bleeding in the United States. Value in Health. 16(2). 325–333. 10 indexed citations
16.
Hoaglin, David C., et al.. (2013). Use of mixed-treatment-comparison methods in estimating efficacy of treatments for heavy menstrual bleeding. European journal of medical research. 18(1). 17–17. 16 indexed citations
17.
Wasiak, Radoslaw, Anna Filonenko, David J. Vanness, et al.. (2013). Impact of Estradiol Valerate/Dienogest on Work Productivity and Activities of Daily Living in Women with Heavy Menstrual Bleeding. Journal of Women s Health. 22(4). 378–384. 11 indexed citations
18.
Trussell, James, et al.. (2012). Burden of unintended pregnancy in the United States: potential savings with increased use of long-acting reversible contraception. Contraception. 87(2). 154–161. 177 indexed citations
19.
Heinemann, Lothar, et al.. (2012). Intercountry Assessment of the Impact of Severe Premenstrual Disorders on Work and Daily Activities. Health Care For Women International. 33(2). 109–124. 46 indexed citations
20.
Heinemann, Lothar, et al.. (2010). Explorative Evaluation of the Impact of Severe Premenstrual Disorders on Work Absenteeism and Productivity. Women s Health Issues. 20(1). 58–65. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026